nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—EPHA2—pulmonary artery—idiopathic pulmonary fibrosis	0.0849	0.147	CbGeAlD
Nilotinib—CDC42BPB—respiratory system—idiopathic pulmonary fibrosis	0.0267	0.0464	CbGeAlD
Nilotinib—MAPK8—respiratory system—idiopathic pulmonary fibrosis	0.0242	0.042	CbGeAlD
Nilotinib—TIE1—respiratory system—idiopathic pulmonary fibrosis	0.021	0.0364	CbGeAlD
Nilotinib—CA3—respiratory system—idiopathic pulmonary fibrosis	0.0165	0.0286	CbGeAlD
Nilotinib—MAPK14—respiratory system—idiopathic pulmonary fibrosis	0.0154	0.0267	CbGeAlD
Nilotinib—FGR—respiratory system—idiopathic pulmonary fibrosis	0.0153	0.0266	CbGeAlD
Nilotinib—EPHB4—respiratory system—idiopathic pulmonary fibrosis	0.0146	0.0253	CbGeAlD
Nilotinib—EPHA2—respiratory system—idiopathic pulmonary fibrosis	0.0143	0.0248	CbGeAlD
Nilotinib—CDC42BPB—lung—idiopathic pulmonary fibrosis	0.0142	0.0247	CbGeAlD
Nilotinib—TEK—respiratory system—idiopathic pulmonary fibrosis	0.0139	0.0242	CbGeAlD
Nilotinib—EPHA3—lung—idiopathic pulmonary fibrosis	0.0135	0.0234	CbGeAlD
Nilotinib—MAPK8—lung—idiopathic pulmonary fibrosis	0.0128	0.0223	CbGeAlD
Nilotinib—PDGFRA—respiratory system—idiopathic pulmonary fibrosis	0.0126	0.0219	CbGeAlD
Nilotinib—MAP4K1—lung—idiopathic pulmonary fibrosis	0.0117	0.0203	CbGeAlD
Nilotinib—CA12—respiratory system—idiopathic pulmonary fibrosis	0.0117	0.0202	CbGeAlD
Nilotinib—TIE1—lung—idiopathic pulmonary fibrosis	0.0111	0.0193	CbGeAlD
Nilotinib—CSF1R—respiratory system—idiopathic pulmonary fibrosis	0.0111	0.0193	CbGeAlD
Nilotinib—BRAF—lung—idiopathic pulmonary fibrosis	0.0107	0.0185	CbGeAlD
Nilotinib—EPHB3—lung—idiopathic pulmonary fibrosis	0.0106	0.0184	CbGeAlD
Nilotinib—KIT—respiratory system—idiopathic pulmonary fibrosis	0.0101	0.0175	CbGeAlD
Nilotinib—PDGFRB—respiratory system—idiopathic pulmonary fibrosis	0.00986	0.0171	CbGeAlD
Nilotinib—HCK—lung—idiopathic pulmonary fibrosis	0.00973	0.0169	CbGeAlD
Nilotinib—ABL2—lung—idiopathic pulmonary fibrosis	0.00967	0.0168	CbGeAlD
Nilotinib—CA1—respiratory system—idiopathic pulmonary fibrosis	0.00923	0.016	CbGeAlD
Nilotinib—EPHA4—lung—idiopathic pulmonary fibrosis	0.00885	0.0154	CbGeAlD
Nilotinib—ABL1—respiratory system—idiopathic pulmonary fibrosis	0.00879	0.0153	CbGeAlD
Nilotinib—CA3—lung—idiopathic pulmonary fibrosis	0.00874	0.0152	CbGeAlD
Nilotinib—MAPK14—lung—idiopathic pulmonary fibrosis	0.00816	0.0142	CbGeAlD
Nilotinib—FGR—lung—idiopathic pulmonary fibrosis	0.00812	0.0141	CbGeAlD
Nilotinib—LCK—lung—idiopathic pulmonary fibrosis	0.00812	0.0141	CbGeAlD
Nilotinib—EPHB4—lung—idiopathic pulmonary fibrosis	0.00773	0.0134	CbGeAlD
Nilotinib—EPHA2—lung—idiopathic pulmonary fibrosis	0.00759	0.0132	CbGeAlD
Nilotinib—TEK—lung—idiopathic pulmonary fibrosis	0.0074	0.0128	CbGeAlD
Nilotinib—CA4—respiratory system—idiopathic pulmonary fibrosis	0.00722	0.0125	CbGeAlD
Nilotinib—EPHB6—lung—idiopathic pulmonary fibrosis	0.00707	0.0123	CbGeAlD
Nilotinib—PDGFRA—lung—idiopathic pulmonary fibrosis	0.0067	0.0116	CbGeAlD
Nilotinib—CA12—lung—idiopathic pulmonary fibrosis	0.00619	0.0107	CbGeAlD
Nilotinib—MAP2K5—lung—idiopathic pulmonary fibrosis	0.00605	0.0105	CbGeAlD
Nilotinib—CA2—respiratory system—idiopathic pulmonary fibrosis	0.00598	0.0104	CbGeAlD
Nilotinib—CSF1R—lung—idiopathic pulmonary fibrosis	0.0059	0.0102	CbGeAlD
Nilotinib—KIT—lung—idiopathic pulmonary fibrosis	0.00536	0.0093	CbGeAlD
Nilotinib—PDGFRB—lung—idiopathic pulmonary fibrosis	0.00523	0.00909	CbGeAlD
Nilotinib—CYP2B6—respiratory system—idiopathic pulmonary fibrosis	0.00511	0.00887	CbGeAlD
Nilotinib—CA1—lung—idiopathic pulmonary fibrosis	0.0049	0.00851	CbGeAlD
Nilotinib—ABL1—lung—idiopathic pulmonary fibrosis	0.00467	0.0081	CbGeAlD
Nilotinib—CA4—lung—idiopathic pulmonary fibrosis	0.00383	0.00665	CbGeAlD
Nilotinib—CA2—lung—idiopathic pulmonary fibrosis	0.00318	0.00552	CbGeAlD
Nilotinib—ABCG2—lung—idiopathic pulmonary fibrosis	0.00294	0.00511	CbGeAlD
Nilotinib—ABCB1—respiratory system—idiopathic pulmonary fibrosis	0.00273	0.00474	CbGeAlD
Nilotinib—CYP2B6—lung—idiopathic pulmonary fibrosis	0.00271	0.00471	CbGeAlD
Nilotinib—TEK—Cell surface interactions at the vascular wall—FN1—idiopathic pulmonary fibrosis	0.0023	0.00542	CbGpPWpGaD
Nilotinib—BLK—Glypican 1 network—TGFB1—idiopathic pulmonary fibrosis	0.00227	0.00536	CbGpPWpGaD
Nilotinib—FGR—Glypican 1 network—TGFB1—idiopathic pulmonary fibrosis	0.00227	0.00535	CbGpPWpGaD
Nilotinib—CA9—HIF-1-alpha transcription factor network—TERT—idiopathic pulmonary fibrosis	0.0022	0.00519	CbGpPWpGaD
Nilotinib—MAP4K1—TGF-beta Signaling Pathway—SMAD3—idiopathic pulmonary fibrosis	0.0021	0.00496	CbGpPWpGaD
Nilotinib—MAPK8—Rac1/Pak1/p38/MMP-2 pathway—FN1—idiopathic pulmonary fibrosis	0.00203	0.00479	CbGpPWpGaD
Nilotinib—MAPK8—IL12 signaling mediated by STAT4—TGFB1—idiopathic pulmonary fibrosis	0.00203	0.00478	CbGpPWpGaD
Nilotinib—CSF1R—Differentiation Pathway—TGFB1—idiopathic pulmonary fibrosis	0.002	0.00472	CbGpPWpGaD
Nilotinib—PDGFRB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—idiopathic pulmonary fibrosis	0.00194	0.00458	CbGpPWpGaD
Nilotinib—MAP4K1—TGF-beta Signaling Pathway—TERT—idiopathic pulmonary fibrosis	0.00193	0.00455	CbGpPWpGaD
Nilotinib—MAPK11—ATF-2 transcription factor network—PLAU—idiopathic pulmonary fibrosis	0.00193	0.00454	CbGpPWpGaD
Nilotinib—PDGFRB—Beta3 integrin cell surface interactions—PLAU—idiopathic pulmonary fibrosis	0.00191	0.0045	CbGpPWpGaD
Nilotinib—LCK—Inflammatory Response Pathway—FN1—idiopathic pulmonary fibrosis	0.0019	0.00448	CbGpPWpGaD
Nilotinib—LCK—IL2 signaling events mediated by PI3K—TERT—idiopathic pulmonary fibrosis	0.00182	0.0043	CbGpPWpGaD
Nilotinib—PDGFRB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FN1—idiopathic pulmonary fibrosis	0.00181	0.00426	CbGpPWpGaD
Nilotinib—MAP4K1—Cardiac Hypertrophic Response—TGFB1—idiopathic pulmonary fibrosis	0.0018	0.00423	CbGpPWpGaD
Nilotinib—PDGFRB—Beta3 integrin cell surface interactions—FN1—idiopathic pulmonary fibrosis	0.00177	0.00418	CbGpPWpGaD
Nilotinib—MAPK8—Syndecan-2-mediated signaling events—TGFB1—idiopathic pulmonary fibrosis	0.00175	0.00413	CbGpPWpGaD
Nilotinib—MAPK8—DNA Damage Response (only ATM dependent)—SMAD3—idiopathic pulmonary fibrosis	0.00171	0.00402	CbGpPWpGaD
Nilotinib—MAP4K1—TGF-beta Signaling Pathway—FN1—idiopathic pulmonary fibrosis	0.0017	0.004	CbGpPWpGaD
Nilotinib—LYN—Cytokine Signaling in Immune system—TOLLIP—idiopathic pulmonary fibrosis	0.00169	0.00398	CbGpPWpGaD
Nilotinib—PDGFRA—ATF-2 transcription factor network—PLAU—idiopathic pulmonary fibrosis	0.00164	0.00388	CbGpPWpGaD
Nilotinib—PDGFRB—Validated targets of C-MYC transcriptional repression—SMAD3—idiopathic pulmonary fibrosis	0.00162	0.00382	CbGpPWpGaD
Nilotinib—MAPK11—Rac1/Pak1/p38/MMP-2 pathway—FN1—idiopathic pulmonary fibrosis	0.00162	0.00381	CbGpPWpGaD
Nilotinib—HCK—IL-3 Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.00151	0.00357	CbGpPWpGaD
Nilotinib—ABL1—Regulation of Telomerase—SMAD3—idiopathic pulmonary fibrosis	0.00149	0.0035	CbGpPWpGaD
Nilotinib—MAPK8—DNA Damage Response (only ATM dependent)—PLAU—idiopathic pulmonary fibrosis	0.00148	0.00349	CbGpPWpGaD
Nilotinib—MAPK14—FGF signaling pathway—PLAU—idiopathic pulmonary fibrosis	0.00148	0.00348	CbGpPWpGaD
Nilotinib—MAPK8—TGF-beta Signaling Pathway—SMAD3—idiopathic pulmonary fibrosis	0.00146	0.00345	CbGpPWpGaD
Nilotinib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—FN1—idiopathic pulmonary fibrosis	0.00146	0.00344	CbGpPWpGaD
Nilotinib—ABCB1—lung—idiopathic pulmonary fibrosis	0.00145	0.00252	CbGeAlD
Nilotinib—MAPK14—AGE/RAGE pathway—SMAD3—idiopathic pulmonary fibrosis	0.00145	0.00342	CbGpPWpGaD
Nilotinib—BRAF—Senescence and Autophagy in Cancer—SMAD3—idiopathic pulmonary fibrosis	0.00139	0.00327	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—TOLLIP—idiopathic pulmonary fibrosis	0.00138	0.00327	CbGpPWpGaD
Nilotinib—MAPK14—ATF-2 transcription factor network—PLAU—idiopathic pulmonary fibrosis	0.00137	0.00324	CbGpPWpGaD
Nilotinib—MAPK8—IL-3 Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.00137	0.00323	CbGpPWpGaD
Nilotinib—LYN—Glypican 1 network—TGFB1—idiopathic pulmonary fibrosis	0.00136	0.00322	CbGpPWpGaD
Nilotinib—ABL1—Regulation of Telomerase—TERT—idiopathic pulmonary fibrosis	0.00136	0.00321	CbGpPWpGaD
Nilotinib—MAPK8—TGF-beta Signaling Pathway—TERT—idiopathic pulmonary fibrosis	0.00134	0.00316	CbGpPWpGaD
Nilotinib—MAPK8—Cardiac Hypertrophic Response—TGFB1—idiopathic pulmonary fibrosis	0.00125	0.00295	CbGpPWpGaD
Nilotinib—ABCG2—HIF-1-alpha transcription factor network—SMAD3—idiopathic pulmonary fibrosis	0.00121	0.00286	CbGpPWpGaD
Nilotinib—MAP4K1—TCR Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.00121	0.00286	CbGpPWpGaD
Nilotinib—BRAF—Senescence and Autophagy in Cancer—PLAU—idiopathic pulmonary fibrosis	0.0012	0.00284	CbGpPWpGaD
Nilotinib—MAP2K5—Cardiac Hypertrophic Response—TGFB1—idiopathic pulmonary fibrosis	0.00119	0.0028	CbGpPWpGaD
Nilotinib—MAPK8—TGF-beta Signaling Pathway—FN1—idiopathic pulmonary fibrosis	0.00118	0.00278	CbGpPWpGaD
Nilotinib—ABCG2—Transmembrane transport of small molecules—ATP11A—idiopathic pulmonary fibrosis	0.00117	0.00276	CbGpPWpGaD
Nilotinib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—FN1—idiopathic pulmonary fibrosis	0.00115	0.00272	CbGpPWpGaD
Nilotinib—BRAF—Senescence and Autophagy in Cancer—FN1—idiopathic pulmonary fibrosis	0.00112	0.00264	CbGpPWpGaD
Nilotinib—LCK—Glypican 1 network—TGFB1—idiopathic pulmonary fibrosis	0.00112	0.00264	CbGpPWpGaD
Nilotinib—ABCG2—HIF-1-alpha transcription factor network—TERT—idiopathic pulmonary fibrosis	0.00111	0.00262	CbGpPWpGaD
Nilotinib—EPHA4—Spinal Cord Injury—TGFB1—idiopathic pulmonary fibrosis	0.00109	0.00258	CbGpPWpGaD
Nilotinib—ABL1—Cell Cycle—SMAD3—idiopathic pulmonary fibrosis	0.00107	0.00253	CbGpPWpGaD
Nilotinib—ABL1—DNA Damage Response (only ATM dependent)—SMAD3—idiopathic pulmonary fibrosis	0.00102	0.0024	CbGpPWpGaD
Nilotinib—HCK—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.00102	0.00239	CbGpPWpGaD
Nilotinib—KIT—Differentiation Pathway—TGFB1—idiopathic pulmonary fibrosis	0.001	0.00236	CbGpPWpGaD
Nilotinib—MAPK14—Senescence and Autophagy in Cancer—SMAD3—idiopathic pulmonary fibrosis	0.001	0.00236	CbGpPWpGaD
Nilotinib—HCK—Focal Adhesion—FN1—idiopathic pulmonary fibrosis	0.000973	0.0023	CbGpPWpGaD
Nilotinib—EPHA3—NRF2 pathway—TGFB1—idiopathic pulmonary fibrosis	0.000967	0.00228	CbGpPWpGaD
Nilotinib—EPHB3—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000966	0.00228	CbGpPWpGaD
Nilotinib—PDGFRB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—idiopathic pulmonary fibrosis	0.000949	0.00224	CbGpPWpGaD
Nilotinib—KIT—Cardiac Progenitor Differentiation—TGFB1—idiopathic pulmonary fibrosis	0.000924	0.00218	CbGpPWpGaD
Nilotinib—BLK—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.00092	0.00217	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.00092	0.00217	CbGpPWpGaD
Nilotinib—FGR—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000917	0.00216	CbGpPWpGaD
Nilotinib—MAP4K1—TGF-beta Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000891	0.0021	CbGpPWpGaD
Nilotinib—LYN—Cell surface interactions at the vascular wall—FN1—idiopathic pulmonary fibrosis	0.000891	0.0021	CbGpPWpGaD
Nilotinib—MAPK8—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—idiopathic pulmonary fibrosis	0.00089	0.0021	CbGpPWpGaD
Nilotinib—ABL1—DNA Damage Response (only ATM dependent)—PLAU—idiopathic pulmonary fibrosis	0.000883	0.00208	CbGpPWpGaD
Nilotinib—BLK—Focal Adhesion—FN1—idiopathic pulmonary fibrosis	0.000882	0.00208	CbGpPWpGaD
Nilotinib—MAPK8—Focal Adhesion—FN1—idiopathic pulmonary fibrosis	0.000882	0.00208	CbGpPWpGaD
Nilotinib—FGR—Focal Adhesion—FN1—idiopathic pulmonary fibrosis	0.000879	0.00207	CbGpPWpGaD
Nilotinib—PDGFRA—Cardiac Progenitor Differentiation—TGFB1—idiopathic pulmonary fibrosis	0.000875	0.00206	CbGpPWpGaD
Nilotinib—MAPK14—Senescence and Autophagy in Cancer—PLAU—idiopathic pulmonary fibrosis	0.000867	0.00204	CbGpPWpGaD
Nilotinib—EPHA3—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000861	0.00203	CbGpPWpGaD
Nilotinib—ABL2—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000861	0.00203	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000858	0.00202	CbGpPWpGaD
Nilotinib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—idiopathic pulmonary fibrosis	0.000846	0.002	CbGpPWpGaD
Nilotinib—BRAF—Regulation of Actin Cytoskeleton—FN1—idiopathic pulmonary fibrosis	0.000845	0.00199	CbGpPWpGaD
Nilotinib—MAPK8—TCR Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000842	0.00199	CbGpPWpGaD
Nilotinib—MAP2K5—Focal Adhesion—FN1—idiopathic pulmonary fibrosis	0.000838	0.00198	CbGpPWpGaD
Nilotinib—MAPK14—TGF-beta Signaling Pathway—SMAD3—idiopathic pulmonary fibrosis	0.000832	0.00196	CbGpPWpGaD
Nilotinib—EPHA8—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000831	0.00196	CbGpPWpGaD
Nilotinib—MAPK8—Corticotropin-releasing hormone—TGFB1—idiopathic pulmonary fibrosis	0.000827	0.00195	CbGpPWpGaD
Nilotinib—EPHB4—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000822	0.00194	CbGpPWpGaD
Nilotinib—EPHA4—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000822	0.00194	CbGpPWpGaD
Nilotinib—LYN—IL-3 Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000821	0.00194	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000816	0.00192	CbGpPWpGaD
Nilotinib—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000809	0.00191	CbGpPWpGaD
Nilotinib—MAPK14—Senescence and Autophagy in Cancer—FN1—idiopathic pulmonary fibrosis	0.000806	0.0019	CbGpPWpGaD
Nilotinib—EPHB2—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000796	0.00188	CbGpPWpGaD
Nilotinib—EPHB6—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000772	0.00182	CbGpPWpGaD
Nilotinib—MAPK14—TGF-beta Signaling Pathway—TERT—idiopathic pulmonary fibrosis	0.000762	0.0018	CbGpPWpGaD
Nilotinib—EPHA2—NRF2 pathway—TGFB1—idiopathic pulmonary fibrosis	0.000752	0.00177	CbGpPWpGaD
Nilotinib—MAP4K1—MAPK Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000735	0.00173	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000733	0.00173	CbGpPWpGaD
Nilotinib—MAPK14—Cardiac Progenitor Differentiation—TGFB1—idiopathic pulmonary fibrosis	0.000731	0.00173	CbGpPWpGaD
Nilotinib—LCK—Cell surface interactions at the vascular wall—FN1—idiopathic pulmonary fibrosis	0.00073	0.00172	CbGpPWpGaD
Nilotinib—PDGFRA—Regulation of Actin Cytoskeleton—FN1—idiopathic pulmonary fibrosis	0.000728	0.00172	CbGpPWpGaD
Nilotinib—EPHA6—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000726	0.00171	CbGpPWpGaD
Nilotinib—MAPK8—DNA Damage Response (only ATM dependent)—TGFB1—idiopathic pulmonary fibrosis	0.000722	0.0017	CbGpPWpGaD
Nilotinib—MAPK14—Cardiac Hypertrophic Response—TGFB1—idiopathic pulmonary fibrosis	0.00071	0.00167	CbGpPWpGaD
Nilotinib—BRAF—Focal Adhesion—FN1—idiopathic pulmonary fibrosis	0.000696	0.00164	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000684	0.00161	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000677	0.0016	CbGpPWpGaD
Nilotinib—MAPK14—TGF-beta Signaling Pathway—FN1—idiopathic pulmonary fibrosis	0.000671	0.00158	CbGpPWpGaD
Nilotinib—TEK—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.00067	0.00158	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.00067	0.00158	CbGpPWpGaD
Nilotinib—KIT—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000661	0.00156	CbGpPWpGaD
Nilotinib—ABCB1—HIF-1-alpha transcription factor network—SMAD3—idiopathic pulmonary fibrosis	0.000656	0.00155	CbGpPWpGaD
Nilotinib—PDGFRB—Regulation of Actin Cytoskeleton—FN1—idiopathic pulmonary fibrosis	0.000656	0.00155	CbGpPWpGaD
Nilotinib—BRAF—Corticotropin-releasing hormone—TGFB1—idiopathic pulmonary fibrosis	0.000653	0.00154	CbGpPWpGaD
Nilotinib—PDGFRA—Allograft Rejection—TGFB1—idiopathic pulmonary fibrosis	0.000636	0.0015	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—ATP11A—idiopathic pulmonary fibrosis	0.000633	0.00149	CbGpPWpGaD
Nilotinib—ABL1—Regulation of Telomerase—TGFB1—idiopathic pulmonary fibrosis	0.000629	0.00148	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000626	0.00148	CbGpPWpGaD
Nilotinib—TEK—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000623	0.00147	CbGpPWpGaD
Nilotinib—MAPK8—TGF-beta Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.00062	0.00146	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000616	0.00145	CbGpPWpGaD
Nilotinib—ABCB1—HIF-1-alpha transcription factor network—TERT—idiopathic pulmonary fibrosis	0.000601	0.00142	CbGpPWpGaD
Nilotinib—PDGFRA—Focal Adhesion—FN1—idiopathic pulmonary fibrosis	0.0006	0.00141	CbGpPWpGaD
Nilotinib—BRAF—Senescence and Autophagy in Cancer—TGFB1—idiopathic pulmonary fibrosis	0.000588	0.00139	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000583	0.00138	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000564	0.00133	CbGpPWpGaD
Nilotinib—LYN—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000552	0.0013	CbGpPWpGaD
Nilotinib—ABL1—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000549	0.0013	CbGpPWpGaD
Nilotinib—PDGFRB—Focal Adhesion—FN1—idiopathic pulmonary fibrosis	0.00054	0.00127	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000526	0.00124	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000523	0.00123	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000515	0.00121	CbGpPWpGaD
Nilotinib—MAPK8—MAPK Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000511	0.00121	CbGpPWpGaD
Nilotinib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—idiopathic pulmonary fibrosis	0.000506	0.00119	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000488	0.00115	CbGpPWpGaD
Nilotinib—MAP2K5—MAPK Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000486	0.00115	CbGpPWpGaD
Nilotinib—MAPK14—TCR Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000479	0.00113	CbGpPWpGaD
Nilotinib—MAPK14—Corticotropin-releasing hormone—TGFB1—idiopathic pulmonary fibrosis	0.00047	0.00111	CbGpPWpGaD
Nilotinib—LYN—Platelet activation, signaling and aggregation—FN1—idiopathic pulmonary fibrosis	0.000469	0.00111	CbGpPWpGaD
Nilotinib—MAPK8—Integrated Pancreatic Cancer Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000461	0.00109	CbGpPWpGaD
Nilotinib—ABL1—Cell Cycle—TGFB1—idiopathic pulmonary fibrosis	0.000455	0.00107	CbGpPWpGaD
Nilotinib—LCK—Immune System—TOLLIP—idiopathic pulmonary fibrosis	0.000452	0.00107	CbGpPWpGaD
Nilotinib—MAPK14—Platelet activation, signaling and aggregation—FN1—idiopathic pulmonary fibrosis	0.000444	0.00105	CbGpPWpGaD
Nilotinib—FGR—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000432	0.00102	CbGpPWpGaD
Nilotinib—ABL1—DNA Damage Response (only ATM dependent)—TGFB1—idiopathic pulmonary fibrosis	0.000431	0.00102	CbGpPWpGaD
Nilotinib—MAPK14—Senescence and Autophagy in Cancer—TGFB1—idiopathic pulmonary fibrosis	0.000423	0.000998	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—FAM13A—idiopathic pulmonary fibrosis	0.000422	0.000995	CbGpPWpGaD
Nilotinib—EPHB3—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000409	0.000965	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000406	0.000957	CbGpPWpGaD
Nilotinib—BRAF—MAPK Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000403	0.000952	CbGpPWpGaD
Nilotinib—FGR—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000401	0.000947	CbGpPWpGaD
Nilotinib—LCK—Platelet activation, signaling and aggregation—FN1—idiopathic pulmonary fibrosis	0.000384	0.000906	CbGpPWpGaD
Nilotinib—ABL2—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000365	0.00086	CbGpPWpGaD
Nilotinib—EPHA3—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000365	0.00086	CbGpPWpGaD
Nilotinib—MAPK14—TGF-beta Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000352	0.000831	CbGpPWpGaD
Nilotinib—EPHA8—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000352	0.00083	CbGpPWpGaD
Nilotinib—EPHB4—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000348	0.000821	CbGpPWpGaD
Nilotinib—EPHA4—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000348	0.000821	CbGpPWpGaD
Nilotinib—EPHB2—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000337	0.000795	CbGpPWpGaD
Nilotinib—TEK—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	0.000327	0.000772	CbGpPWpGaD
Nilotinib—EPHB6—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000327	0.000772	CbGpPWpGaD
Nilotinib—UGT1A1—NRF2 pathway—TGFB1—idiopathic pulmonary fibrosis	0.000321	0.000757	CbGpPWpGaD
Nilotinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000314	0.00074	CbGpPWpGaD
Nilotinib—PDGFRB—MAPK Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000313	0.000739	CbGpPWpGaD
Nilotinib—EPHA6—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000308	0.000725	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000305	0.000721	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.000304	0.000717	CbGpPWpGaD
Nilotinib—MAPK14—MAPK Signaling Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000291	0.000686	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—SMAD3—idiopathic pulmonary fibrosis	0.00029	0.000683	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000284	0.000669	CbGpPWpGaD
Nilotinib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000275	0.00065	CbGpPWpGaD
Nilotinib—HCK—Disease—SMAD3—idiopathic pulmonary fibrosis	0.000267	0.00063	CbGpPWpGaD
Nilotinib—MAPK14—Integrated Pancreatic Cancer Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000262	0.000619	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.00026	0.000613	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000259	0.00061	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000246	0.000581	CbGpPWpGaD
Nilotinib—LYN—Platelet activation, signaling and aggregation—TGFB1—idiopathic pulmonary fibrosis	0.000246	0.000581	CbGpPWpGaD
Nilotinib—HCK—Disease—TERT—idiopathic pulmonary fibrosis	0.000244	0.000576	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000242	0.00057	CbGpPWpGaD
Nilotinib—ABCB1—Allograft Rejection—TGFB1—idiopathic pulmonary fibrosis	0.000241	0.000568	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.00024	0.000567	CbGpPWpGaD
Nilotinib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—idiopathic pulmonary fibrosis	0.000233	0.00055	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000229	0.00054	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—PLAU—idiopathic pulmonary fibrosis	0.000213	0.000502	CbGpPWpGaD
Nilotinib—FGR—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	0.000211	0.000497	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—SMAD3—idiopathic pulmonary fibrosis	0.000208	0.00049	CbGpPWpGaD
Nilotinib—LCK—Platelet activation, signaling and aggregation—TGFB1—idiopathic pulmonary fibrosis	0.000202	0.000476	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—FN1—idiopathic pulmonary fibrosis	0.000198	0.000467	CbGpPWpGaD
Nilotinib—BRAF—Disease—SMAD3—idiopathic pulmonary fibrosis	0.000191	0.00045	CbGpPWpGaD
Nilotinib—BRAF—Disease—TERT—idiopathic pulmonary fibrosis	0.000175	0.000412	CbGpPWpGaD
Nilotinib—KIT—Disease—SMAD3—idiopathic pulmonary fibrosis	0.000174	0.00041	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000172	0.000405	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000169	0.0004	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—SMAD3—idiopathic pulmonary fibrosis	0.000164	0.000388	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000161	0.00038	CbGpPWpGaD
Nilotinib—KIT—Disease—TERT—idiopathic pulmonary fibrosis	0.000159	0.000375	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000155	0.000366	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—TERT—idiopathic pulmonary fibrosis	0.000151	0.000355	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—SMAD3—idiopathic pulmonary fibrosis	0.000148	0.00035	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—SMAD3—idiopathic pulmonary fibrosis	0.000148	0.000349	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000147	0.000348	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000137	0.000322	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—TERT—idiopathic pulmonary fibrosis	0.000136	0.00032	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000135	0.000318	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000134	0.000315	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.00013	0.000306	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000129	0.000305	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000129	0.000304	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	0.000127	0.000299	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	0.000126	0.000298	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000124	0.000291	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—TGFB1—idiopathic pulmonary fibrosis	0.000123	0.000289	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000122	0.000289	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000122	0.000287	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	0.00012	0.000284	CbGpPWpGaD
Nilotinib—LCK—Disease—SMAD3—idiopathic pulmonary fibrosis	0.000119	0.000281	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—idiopathic pulmonary fibrosis	0.000119	0.00028	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000115	0.000272	CbGpPWpGaD
Nilotinib—HCK—Disease—TGFB1—idiopathic pulmonary fibrosis	0.000113	0.000267	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000111	0.000263	CbGpPWpGaD
Nilotinib—LCK—Disease—TERT—idiopathic pulmonary fibrosis	0.000109	0.000257	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000109	0.000257	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	0.000108	0.000254	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	0.000105	0.000249	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—TGFB1—idiopathic pulmonary fibrosis	0.000104	0.000245	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000104	0.000245	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	0.000102	0.00024	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	9.81e-05	0.000231	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	9.63e-05	0.000227	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	9.5e-05	0.000224	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	9.3e-05	0.000219	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	9.28e-05	0.000219	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	8.82e-05	0.000208	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	8.36e-05	0.000197	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—SMAD3—idiopathic pulmonary fibrosis	8.33e-05	0.000196	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	8.19e-05	0.000193	CbGpPWpGaD
Nilotinib—BRAF—Disease—TGFB1—idiopathic pulmonary fibrosis	8.08e-05	0.000191	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	7.76e-05	0.000183	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TERT—idiopathic pulmonary fibrosis	7.62e-05	0.00018	CbGpPWpGaD
Nilotinib—KIT—Disease—TGFB1—idiopathic pulmonary fibrosis	7.36e-05	0.000174	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	7.17e-05	0.000169	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—TGFB1—idiopathic pulmonary fibrosis	6.96e-05	0.000164	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	6.82e-05	0.000161	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—FN1—idiopathic pulmonary fibrosis	6.71e-05	0.000158	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—TGFB1—idiopathic pulmonary fibrosis	6.27e-05	0.000148	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	5.71e-05	0.000135	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	5.66e-05	0.000134	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	5.15e-05	0.000122	CbGpPWpGaD
Nilotinib—LCK—Disease—TGFB1—idiopathic pulmonary fibrosis	5.04e-05	0.000119	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	4.88e-05	0.000115	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	4.39e-05	0.000104	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	4.3e-05	0.000101	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	4.08e-05	9.62e-05	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TGFB1—idiopathic pulmonary fibrosis	3.53e-05	8.32e-05	CbGpPWpGaD
